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Abstract: Studies suggesting that medicinal plants are not chosen at random are becoming more
common. The goal of this work is to shed light on the role of botanical families in ethnobotany,
depicting in a molecular phylogenetic frame the relationships between families and medicinal uses
of vascular plants in several Catalan-speaking territories. The simple quantitative analyses for
ailments categories and the construction of families and disorders matrix were carried out in this
study. A Bayesian approach was used to estimate the over- and underused families in the medicinal
flora. Phylogenetically informed analyses were carried out to identify lineages in which there is
an overrepresentation of families in a given category of use, i.e., hot nodes. The ethnobotanicity
index, at a specific level, was calculated and also adapted to the family level. Two diversity indices
to measure the richness of reported taxa within each family were calculated. A total of 47,630 use
reports were analysed. These uses are grouped in 120 botanical families. The ethnobotanicity index
for this area is 14.44% and the ethnobotanicity index at the family level is 68.21%. The most-reported
families are Lamiaceae and Asteraceae and the most reported troubles are disorders of the digestive
and nutritional system. Based on the meta-analytic results, indicating hot nodes of useful plants
at the phylogenetic level, specific ethnopharmacological research may be suggested, including a
phytochemical approach of particularly interesting taxa.
Keywords: botanical families; Catalan-speaking territories; database; diversity indices; ethnobotany;
ethnomedicine; medicinal plants; phylogeny
1. Introduction
Ethnobotany is a relatively recent denomination for a discipline that studies plant
names, uses and management by human societies from ancient to current times, aiming at
their projection to the future [1]. Even if a precedent of this term, botanical ethnography,
was coined to name the investigation of any plant materials in archaeology in order to
unveil their uses and symbolisms [2], Harshberger [1] himself emphasised the fact that
ethnobotanical findings should not only constitute an inventory of old knowledge, but
should be relevant for current productive activities. From those dates to the present times,
ethnobotany undertook methodological innovations, but maintained the double approach
of recording and preserving the ancient uses of plants by people—which contributes to
describing human lifestyles—and aiming to improve human life conditions [3]. This
is why the collection of plant uses related to health, mostly medicinal and food ones,
are predominant in ethnobotanical research, although other uses are relevant as well [4].
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According to the importance of using folk local knowledge to preserve and improve health,
not a few drugs have been developed based on their ethnobotanical background, such
as, to quote just two famous and recent ones, the oseltamivir, used against chicken flu [5],
and the antimalarial artemisinin [6]. Additionally, in agreement with this, medical or
pharmaceutical ethnobotany, the botanical side of ethnopharmacology, is one of the main
pillars of the discipline, particularly in industrialised countries [7,8].
In Europe, the Catalan linguistic domain, the framework of the present research, is
among the better-known Iberian areas from an ethnobotanical viewpoint [9]. The amount
of information recollected until now allows us to start conducting research involving
comparison among several territories [4,10], in order to establish general patterns in eth-
nobotanical knowledge.
In the above-referred geographical area, as in general in Europe and worldwide, the
predominant ethnobotanical research has been an ethnofloristic one [11,12]. Nevertheless,
efforts are being devoted toward finding other complementary approaches, such as studies
focused on plants used for ailments related to a determined system, and on the validation
of the ethnobotanical evidence with chemical or pharmacological data [13]. Moreover, the
potentially predictive role of molecular phylogeny in bioprospection and in phytochem-
istry [14,15] and the concept of ethnobotanical convergence [16,17] has opened the way
to integrate ethnobotany with genetic (including molecular phylogenetic), genomic (and
other “omic” disciplines) and phytochemical approaches [18,19].
One of the aspects always addressed in ethnobotanical investigation is the distribution
of the plant taxa recorded in botanical families, since, after the number of plant species
known in a given territory, the families in which they are included is one of the most evident
pieces of information. Even if some deeper analyses of the causes for some predominating
families have been undertaken [18,20–23], work in this field is still lacking, including
territories other than those already considered, and taking into account, among others,
phylogenetic issues.
Several statistical methods have been used to test whether a specific taxonomic group
is over- or underrepresented in an ethnobotanical flora in comparison to overall local flora.
Although the linear regression analysis [21] and binomial analysis [24] have been widely
used, more recent studies have pointed out some limitations in these previous analytical
methods, and propose a Bayesian approach in order to analyse the over- and underused
plant groups [22,23]. This method allows us to consider the uncertainty of the proportion of
medicinal plant species in the overall flora and shows its robustness in small datasets [22].
In this context, the aim of this work is to shed light on the role of botanical families
in ethnobotany, depicting, in a molecular phylogenetic frame, the relationships between
botanical families and medicinal uses of vascular plants in several Catalan-speaking terri-
tories (Formentera, Mallorca, and Catalonia, Northern Catalonia included). This will allow
us to ascertain the most used families in pharmaceutical ethnobotany in this area and the
possible phylogenetic reasons accounting for this, and to find out whether some families
are more focused on some particular health conditions than others.
2. Results and Discussion
For the areas under consideration, we analysed a total of 47,630 use reports correspond-
ing to medicinal uses of vascular plants in human medicine registered in our database,
including data from ethnobotanical research performed from 1991 until today, in order to
study different aspects related to the botanical families to which these uses belong, and the
disorders they refer to.
Based on these data, we can state that the medical ethnobotany of the Catalan-speaking
territories scrutinised is distributed in 120 botanical families of vascular plants (seven to
pteridophytes, five to gymnosperms and 108 to angiosperms). These families include
894 taxa, with medicinal uses, of which 41 have only been determined at generic level (the
remaining majority, at specific and infraspecific levels).
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The ethnobotanicity index (EI) for the studied area is 14.44%. In addition, the total
considered flora ([25], see materials and methods for precisions) is at least slightly larger
than that of the territories object of the present research, since some plants present in the
places not covered here (i.e., Valencian area and some of the Balearic Islands) do not grow
in the areas here concerned. This just means that, in fact, the EI in the studied area has been
slightly underestimated. The result, as calculated, is higher than in other Mediterranean
areas like Arrábida Natural Park, Portugal (12.1%; [26]), Monti Sicani Regional Park, Italy
(12.7%, [27]) or the northwest Basque Country (12%; [28]), and lower than that of Serra
de São Mamede, Portugal (23.1%; [29]), in the same biogeographical region, or that of
Keelakodankulam, India (20.17%; [30]), in a quite distant and floristically different area.
The EI was conceived [31], and is usually calculated, for species and infraspecific taxa.
Nevertheless, as the present paper focuses on families too, we calculated the EI for this
taxonomic category (excluding the 15 non-native families, not present in the flora used
as a basis). We found a familiar EI of 68.21%, indicating that almost three-quarters of the
families in the area considered contained plants used in pharmaceutical ethnobotany. We
believe that it would be of interest to calculate this parameter for other ethnofloras, in order
to be able to compare the rates of families hosting useful plants.
2.1. Most Reported Families
Among the 10 most cited families (Table 1), which represent 57.34% of total use reports,
we find some of the most relevant in ethnobotanical studies in the Mediterranean, namely
Lamiaceae (15.40%), Asteraceae (11.90%) or Rosaceae (5.57%). These are large in terms of
number of taxa, Asteraceae being the largest one [32]. These families are cosmopolitan
and well represented in our territories, but also, particularly in Lamiaceae and Rosaceae,
they are economically very significant, thanks to aromatic plants in Lamiaceae [33] and
edible fruits and ornamental uses in Rosaceae [34]. In ethnofloristic works conducted
in Mediterranean areas, these three families are almost always predominate at the top
of the list, and also some others such as Fabaceae and Apiaceae [11,12,26,35–45]. From
this, the simple but clear idea can be deduced, that people use with preference (or at least
importantly) the plants that they easily find not far from their place of daily life, as Johns
et al. [46] and Bonet et al. [47] stated.
Table 1. Top ten families by citations, with number of use reports (UR), UR percentage and number
of taxa with uses present in the flora of the territories studied.
Family UR UR (%) Number of Taxa with Medicinal Uses
Lamiaceae 7336 15.40 75
Asteraceae 5667 11.90 116
Rosaceae 2652 5.57 57
Malvaceae 2298 4.82 13
Adoxaceae 1971 4.14 3
Apiaceae 1661 3.49 26
Amaryllidaceae 1544 3.24 8
Oleaceae 1468 3.08 9
Pinaceae 1383 2.90 10
Rutaceae 1329 2.79 12
In addition, partly due to the restructuring of families following the APG IV last
update [48], in which Sterculiaceae and Tiliaceae have become part of the family Malvaceae,
this latter family also appears in the top 10 most reported families, with 4.82%.
The remaining most quoted families are Adoxaceae (4.14%), Apiaceae (3.49%), Amaryl-
lidaceae (3.24%), Oleaceae (3.08%), Pinaceae (2.90%) and Rutaceae (2.79%). Four of these
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families (Apiaceae, Oleaceae, Pinaceae, Rutaceae) have not been the object of any recent
systematic restructuring, and they are classically important in terms of medicinal taxa.
Conversely, the Adoxaceae, with only ca. 225 species worldwide [49], and just six of
them in the studied area [25], now host Sambucus nigra, one of the most used plants in
the Mediterranean region and, in particular, in the Catalan-speaking territories [50,51],
which has recently been transferred from the Caprifoliaceae. Similarly, the Amaryllidaceae
exhibit a significant rate owing to the fragmentation of the Liliaceae lato sensu in several
families and the attribution of genus Allium to this family, which is also very relevant in
Mediterranean pharmaceutical ethnobotany [42].
Moerman [20] concluded that although in a random universe the size of a family
would be the best predictor of its medicinal potential in number of taxa, the Asteraceae
contain more medicinal plants than random would indicate, so that size is not the only
condition for this success. Moerman et al. [21] found, through a comparative analysis of
several geographically distant medicinal floras, that the five most important medicinal
plant families in four very differentiated regions (North America, Korea, Kashmir, Chiapas
highlands) were delineated by only nine plant families (Araceae, Bignoniaceae, Ericaceae,
Euphorbiaceae, Fabaceae, Loganiaceae, Malvaceae, Rosaceae, Solanaceae), accounting for
the existence of a global pattern of human knowledge. Indeed, to include a fifth area
(Ecuador), only three more families were necessary (Apiaceae, Asteraceae, Lamiaceae). In
the same line, six out of the top ten families in the present study are among the 14 most
quoted ones in the five North American, Mesoamerican, South American and Asian
territories investigated by Moerman et al. [21], those reported above plus Liliaceae and
Ranunculaceae. The only top families in this paper not appearing in Moerman et al. [21]
are Adoxaceae, Oleaceae, Pinaceae and Rutaceae (considering the Amarillydaceae included
in the Liliaceae lato sensu, as this family was referred to in the aforementioned work).
2.2. Over- and Underuse of Plant Groups and Plant Families
Results for the over- and underused high taxonomic groups are shown in Table 2.
Gymnosperms and monocots are the only two groups that differ from the common pro-
portion. The observed proportion was 0.1709 and ranges from 16% and 18% with 95% of
probability and, consequently, we can refuse the null hypothesis for these groups. While
monocots are underused, gymnosperms are overused. The proportion of used monocots is
very low, and the 95% posterior credible interval very narrow. Contrarily, gymnosperms
show the highest proportion of the used plants, and a larger interval, possibly related,
according to Weckerle et al. [22], to their small number of species.
Table 2. Over- and underused high taxonomic groups in the Catalan-speaking territories.
Taxonomic Group (J) nj xj Inf. Θj Sup.
Gymnosperms * 34 19 0.394 0.56 0.712
Eudicots-superrosids 1401 273 0.175 0.19 0.216
Pteridophytes 69 18 0.172 0.26 0.376
Eudicots-superasterids 2178 395 0.166 0.18 0.198
ANA-grade 1 1 0.158 1.00 0.987
Magnoliids 7 3 0.157 0.43 0.755
Early-diverging eudicots 175 22 0.085 0.13 0.183
Monocots * 782 63 0.064 0.08 0.102
Total/common 4647 794 0.160 0.17 0.182
nj: number of plant taxa in the overall flora; xj: number of medicinal plant taxa; θj: proportion of medicinal
species; Inf. and Sup.: The 95% posterior credible interval of θj. * Taxonomic groups differing from H0.
The families whose 95% posterior credible interval lies above the interval of the overall
proportion of flora (0.160, 0.182) are listed in Table 3. These overused families are families
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represented by a small number of genera, and most of them having medicinal uses, that
is, with high proportions. The preponderance of woody species over herbaceous among
the most used has been discussed by several authors [20,52–54]. Fagaceae, Rutaceae and
Cannabaceae are the three most overused families. The woody families such as Fagaceae,
Pinaceae and Cupressaceae (the last two gymnosperms) together with some shrubby
families such as Buxaceae, Rhamnaceae and Ericaceae are overrepresented in the medicinal
Catalan flora, but in approximately the same proportion as weedy plant families, such as
Equisetaceae, Asphodelaceae or Urticaceae.
Table 3. Overused plant families in the studied area.
Family (J) nj xj Inf. θj Sup. Margin
Fagaceae 15 11 0.476 0.73 0.890 0.294
Rutaceae 15 11 0.476 0.73 0.890 0.294
Cannabaceae 3 3 0.398 1.00 0.994 0.216
Pinaceae 15 9 0.354 0.60 0.802 0.172
Cucurbitaceae 13 8 0.351 0.62 0.823 0.169
Equisetaceae 8 5 0.299 0.63 0.863 0.117
Cupresaceae 15 8 0.299 0.53 0.753 0.117
Oleaceae 15 8 0.299 0.53 0.753 0.117
Buxaceae 2 2 0.292 1.00 0.992 0.110
Apocynaceae 13 7 0.289 0.54 0.770 0.107
Rhamnaceae 13 7 0.289 0.54 0.770 0.107
Myrtaceae 4 3 0.284 0.75 0.947 0.102
Lamiaceae 207 67 0.264 0.32 0.390 0.082
Asphodelaceae 12 6 0.251 0.50 0.749 0.069
Urticaceae 10 5 0.234 0.50 0.766 0.052
Crassulaceae 38 14 0.234 0.37 0.528 0.052
Ericaceae 22 9 0.232 0.41 0.615 0.050
Rosaceae 190 54 0.225 0.28 0.352 0.043
Solanaceae 37 13 0.218 0.35 0.514 0.036
Araceae 11 5 0.211 0.45 0.723 0.029
Polypodiaceae 3 2 0.194 0.67 0.932 0.012
Adoxaceae 6 3 0.184 0.50 0.816 0.002
nj: number of plant taxa in the overall flora; xj: number of medicinal plant taxa; θj: proportion of medicinal
species; Inf. and Sup.: The 95% posterior credible interval of θj.
The families whose 95% posterior credible interval lies below the interval of the overall
proportion of flora (0.160, 0.182) are listed in Table 4. Usually, these are families comprising
a large number of species in the local flora and with little representation in the medicinal
one. In the present study, only nine families are underused, Cyperaceae, Plumbaginaceae
and Poaceae, the most underused. Three families, Poaceae, Juncaceae and Cyperaceae
belong to the underrepresented high group of monocots. In the present study, most of
members of the underused families are herbaceous plants.
Table 4. Underused plant families in the studied area.
Family (J) nj xj Inf. Θj Sup. Margin
Fabaceae 383 45 0.089 0.12 0.154 0.006
Ranunculaceae 126 9 0.038 0.07 0.130 0.030
Brassicaceae 256 22 0.058 0.09 0.127 0.033
Orobanchaceae 78 4 0.021 0.05 0.125 0.035
Caryophyllaceae 233 18 0.050 0.08 0.119 0.041
Juncaceae 45 1 0.005 0.02 0.115 0.045
Poaceae 417 22 0.035 0.05 0.079 0.081
Plumbaginaceae 80 1 0.003 0.01 0.067 0.093
Cyperaceae 131 2 0.005 0.02 0.054 0.106
nj: number of plant taxa in the overall flora; xj: number of medicinal plant taxa; θj: proportion of medicinal
species; Inf. and Sup.: The 95% posterior credible interval of θj.
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2.3. Genera with Folk Medicinal Uses
The 120 families recorded are represented herein by 432 genera. If we analyse the
number of genera per family, the results vary slightly, and families with more genera are
Asteraceae (52), Fabaceae (30) and Lamiaceae (25). Apart from the two families with the
most use reports, here appears the Fabaceae family (765 UR, 1.61%), although not being
among the top ten. Despite not having a high percentage, Fabaceae is a relevant family
in the Mediterranean flora (even being indicative of the Mediterranean character of a
territory; [55]) and ethnoflora [42]. Conversely, Adoxaceae with a large number of use
reports (1,971 UR, 4.14%) is very asymmetrically distributed in only two genera, Sambucus
(99.9%) and Viburnum (0.1%), which would be explained by the change of family, since
they previously belonged to the Caprifoliaceae, yet with the APG system, a new familiar
delimitation of the Adoxaceae was created for these two genera, and for three more not
present in our territory. On the other hand, there are 60 botanical families in which all
the reports are grouped in a single genus. Some examples, representing pteridophytes,
gymnosperms and angiosperms, are the Equisetaceae, a family with 578 UR exclusive
of the genus Equisetum, the only one in the family to be present in the studied area, and
the Taxaceae and the Juglandaceae families, with 17 and 570 UR respectively, exclusively
represented by their corresponding single species growing in the area, Taxus baccata L. and
Juglans regia L. There are also families that concentrate all the medicinal records in one
genus, although they have other representatives in the territories studied like Liliaceae
stricto sensu, with six genera in the concerned area, but with all UR from only one, Lilium.
2.4. Plants not Appearing in the Flora of the Studied Area
Concerning plants not appearing in the flora of the territories studied ([25]; see mate-
rials and methods for details), there are 15 families not present in the flora of our territory,
representing 12.5% of the total number of families. Examples are Actinidiaceae, Myris-
ticaceae and Zingiberaceae. These families contain very renowned and used medicinal
plants, some of them used first for food purposes, such as Actinidia chinensis Planch., Myris-
tica fragrans Houtt. and Zingiber officinalis Roscoe. In addition, there are 62 taxa not present
in our territory, yet belonging to families that nonetheless are present thanks to other
genera; this is the case of Cinnamomum verum J.Presl (Lauraceae), Cocos nucifera L. (Are-
caceae) or Coffea arabica L. (Rubiaceae), to give some examples. Even the two most quoted
families, in terms of UR, Asteraceae and Lamiaceae, very abundant in wild representatives
in the region under investigation, include non-native plants in the local ethnoflora, some
examples are Echinacea purpurea (L.) Moench and Stevia rebaudiana (Bertoni) Bertoni, and
Monarda didyma L., Ocimum basilicum L., and Perilla frutescens (L.) Britton, respectively. It is
important to emphasise that a number of plants ethnobotanically used are not present in
the Catalan flora [25], and yet they are important in local ethnobotany. Indeed, in a work in
progress regarding in the Catalan linguistic area we are recording a non-negligible number
and percentage of UR attributed to non-native plants [56].
2.5. Most Reported Troubles
We grouped the troubles or systems addressed in 15 categories (Table 5). The four most
addressed troubles, representing 61.01% of all use reports, are disorders of the digestive and
nutritional system (11,754 UR, 24.68%), followed at a great distance (approximately half of
the use reports) by respiratory system disorders (6418 UR, 13.47%), skin or subcutaneous
tissue disorders (5588 UR, 11.73%) and circulatory system and blood disorders (5299 UR,
11.13%). Most uses are addressing mild and chronic illnesses, which agrees with the most
widespread idea on the main focuses of pharmaceutical ethnobotany and phytotherapy
in general [57], but in some cases, they are also pointing to acute and more severe health
troubles, like cardiovascular and pulmonary ones, and even cancer.
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Table 5. Medicinal uses grouped in troubles or systems addressed with number and percentage of
use reports (UR).
Troubles or Systems Addressed (Code) UR UR (%)
Digestive system and nutritional disorders (DN) 11,754 24.68
Respiratory system disorders (R) 6418 13.47
Skin and subcutaneous tissue disorders (SS) 5588 11.73
Circulatory system and blood disorders (CB) 5299 11.13
Infections and infestations (II) 3831 8.04
Genitourinary system disorders (G) 3618 7.60
Musculoskeletal system disorders and traumas (MT) 3493 7.33
Nervous system and mental disorders (NM) 2546 5.35
Sensory system disorders (S) 1975 4.15
Pain and inflammations (PI) 1224 2.57
Pregnancy, birth and puerperal disorders (PBP) 554 1.16
Endocrine system and metabolic disorders (EM) 470 0.99
Tonic and restorative (TR) 406 0.85
Poisoning (P) 361 0.76
Immune system disorders and neoplasia (IN) 93 0.20
2.6. Relationship between Families and Uses
One of the most important aims of this work is to study the possible relationships
between plant families and categories of medicinal uses, i.e., troubles or systems addressed.
We analysed the correspondences between families and health diseases, and will now
comment on the most relevant findings.
A general consideration of the relationship between families and UR in a phylogenetic
frame (Figure 1) shows, within the angiosperms, that the superasterids clearly host the
largest number of uses, as well as the largest number of families with an important number
of UR, in comparison with the remaining large groups. In each of these, only one or
a few families play a protagonist role, such as Malvaceae, Rosaceae and Rutaceae in
the superrosids, Ranunculaceae in the eudicots, and Amaryllidaceae and Poaceae in the
monocots. Magnoliids and basal angiosperms are not of much significance in terms of UR.
It is worth mentioning that, in the asterids, most UR are concentred in the most evolved
clade, formed by the campanulids plus the lamiids. As for the gymnosperms, the Pinaceae
accumulate most UR.
The analysis of the percentages of UR related to the different troubles/systems within
each family (Figure 2) denotes that the highest rates are rather widespread at the phylo-
genetic scale. In any case, it clearly appears that a large number of families have exhibit
digestive and nutritional problems as the most treated ones (mean percentage: 24.56),
which is in agreement with the above-mentioned idea that ethnobotany and phytotherapy
importantly address mild, daily health constraints. Nevertheless, in the vast majority of
families, there are also strong rates of uses focused on circulatory and blood, and respiratory
ailments (mean percentages: 14.30 and 11.03, respectively), most of which are not so mild.
Finally, some disorders are very scarcely addressed in the pharmaceutical ethnoflora under
consideration, such as those linked to endocrine and metabolic, and immune systems, as
well as to neoplasia (mean percentages: 0.35 and 0.16, respectively).
If we analyse the percentage of use reports of families for each disorder (Figure 2),
10 out of the 15 trouble/system categories established are dominated by the two fami-
lies with most UR in general, Lamiaceae (six categories: Circulatory system and blood
disorders; pain and inflammation; digestive system and nutritional disorders; skin and
subcutaneous tissue disorders; respiratory system disorders; tonic and restorative) and
Asteraceae (four categories: Endocrine system and metabolic disorders; infections and
infestations; musculoskeletal system disorders and traumas; sensory system disorders).
The well-known important presence and diversity of essential oil compounds in the Lami-
aceae [58] account—together with the size of the family, as already commented—for its
relevance in many medicinal fields related to antiseptic properties, which could explain
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the prevalence in digestive, dermic and respiratory disorders. Similarly, the abundance,
among other compounds, of terpene compounds (including sesquiterpene lactones) in the
Asteraceae [59] is logically at the basis of their uses for different ailments, again considering
the size and diversity within the family.
Figure 1. Heatmap depicting the distribution of use records among plant families and the addressed
troubles/systems. Abbreviations, as quoted in the figure, are as follows. CB, circulatory system
and blood disorders; PI, pain and inflammations; DN, digestives system and nutritional disorders;
P, poisoning; EM, endocrine system and metabolic disorders; PBP, pregnancy, birth and puerperal
disorders; G, genitourinary system disorders; II, infections and infestations; IN, immune system
disorders and neoplasia; NM, nervous system and mental disorders; MT, musculoskeletal system
disorders and traumas; SS, skin and subcutaneous tissue disorders; R, respiratory system disorders;
S, sensory system disorders; TR, tonic and restorative.
Concerning Asteraceae, we want to underline two troubles in particular. First, the
uses for the musculoskeletal system disorders and traumas, explained by Arnica montana L.
(335 UR, 52.59%) and other species of this family (Arctium minus (Hill) Bernh., Doronicum
grandiflorum Lam., all of the Inula genus, Jasonia saxatilis (Lam.) Guss., Pallenis spinosa (L.)
Cass. and Pulicaria dysenterica (L.) Gaertn.) referred to with the popular name “àrnica”
(189 UR, 29.67%). In total, the ethnotaxon constituted by Arnica montana and the aforemen-
tioned related taxa accumulates 82.26% of the Asteraceae UR employed for musculoskeletal
system disorders and traumas, specially bruises. This medicinal plant complex has been
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well studied in the Iberian Peninsula and Balearic Islands from a botanical and ethnophar-
macological point of view [60]. Secondly, the uses for the endocrine system and metabolic
disorders are due to hypoglycaemic activity (259 UR, 98.48%) of several species of the genus
Centaurea, representing, with 180 UR, the 68.44% of this property, abundantly registered in
this genus [61].
Figure 2. Heatmaps depicting percentages of use reports related to the different troubles/systems
within each family, and percentages of use reports of families for each trouble/system. Abbreviations,
as quoted in the figure, are as follows. CB, circulatory system and blood disorders; PI, pain and
inflammations; DN, digestives system and nutritional disorders; P, poisoning; EM, endocrine system
and metabolic disorders; PBP, pregnancy, birth and puerperal disorders; G, genitourinary system
disorders; II, infections and infestations; IN, immune system disorders and neoplasia; NM, nervous
system and mental disorders; MT, musculoskeletal system disorders and traumas; SS, skin and
subcutaneous tissue disorders; R, respiratory system disorders; S, sensory system disorders; TR, tonic
and restorative.
In the other five categories, the prominence of a family in the treatment of a prob-
lem is basically due to one or a very few taxa. Amaryllidaceae are the most quoted
in fighting against poisoning cases (21.33%), with all the reports concentrated on a few
species of the genus Allium, which has been reported with this function, and is, for in-
stance, used worldwide against snakebites [62,63]. The dominance of Rutaceae in the
pregnancy/childbirth/puerperal treatment is basically explained (27.44%) by the genus
Ruta, with three species. This family is closely followed by the Saxifragaceae (22.56%),
because of a few species of Saxifraga. Irrespective of the fact of containing plants used
for food purposes in ethnobotany, both genera mentioned are among those most famous
abortifacients recorded in folk medicine [64,65], this proving their relationship with the life
period concerned (e.g., labour inducing, post-labour coadjuvant, dangerous in pregnancy).
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Poaceae are the most relevant regarding the genitourinary system (17.66%), mostly
by Zea mays L., followed at a considerable distance by Cynodon dactylon (L.) Pers., both
(especially the first one) are much reputed as diuretic [66]. Ranunculaceae are the top family
in addressing neoplasia (21.51%), because of Ranunculus parnassifolius L., a high mountain
plant much appreciated popularly for this purpose in a Pyrenean region [45,67]. Finally,
Malvaceae leads the ranking in troubles related to the nervous system and mental disorders
(29.58%). The success in this use is basically explained by the genus Tilia (733 UR, 97.34%)—
recently incorporated into the Malvaceae, where Tiliaceae have been merged—very popular
and largely studied as hypnotic, sedative and tranquilizer [68,69].
2.7. Phylogenetic Distribution of Families with Medicinal Use
To investigate the degree of phylogenetic clustering of families for each trouble or
system, and to detect hot nodes for further studies, we mapped the reported medicinal
uses grouped in the 15 troubles or systems addressed on the phylogeny of the families.
A robust hot node appears in three medicinal groups: immune system disorders
and neoplasia; pain and inflammation; and pregnancy, birth and puerperal disorders.
The hot node is constituted by the Iridaceae and three families classically included in the
Liliaceae l.s., Amaryllidaceae, Asparagaceae, and Asphodelaceae. The last three families
also constitute a hot node clade for tonic and restorative. In addition, only Amaryllidaceae
and Asparagaceae are hot nodes for the endocrine system and metabolic disorders.
Tonic and restorative activities also have another robust hot node, constituted by
Betulaceae, Juglandaceae and Fagaceae. For the endocrine system and metabolic disorders,
the clade of Apiaceae and Araliacaeae was detected as relevant.
Finally, two robust hot nodes appear for poisoning, on the one hand, Cucurbitaceae
and Coriariaceae, and on the other hand Malvaceae, Cistaceae and Thymelaeaceae.
2.8. Diversity Indices
The results of the Shannon and Margalef indices for each family are shown in Supple-
mentary Materials. Although the values of the two indices are zero for several families and
some of them present low values, such as the Vitaceae (H = 0.01 and k = 0.11), other families
show a moderate diversity. The family Asteraceae is the one that presents the highest
diversity according to the Shannon index (H = 1.45), while, according to the Margalef index,
the Campanulaceae is the family with the greatest diversity (k = 0.70). These differences are
due to the fact that the Margalef index is higher when the number of taxa and the number
of use reports are equal or close within a family, while if there are many use reports for a
few taxa, the diversity decreases. Despite showing a different sensitivity to the variation in
the number of taxa and use reports, both indices are well correlated, (r = 0.841, p < 0.001 for
a whole dataset). For this reason, we believe the two indices are robust and can be used to
measure ethnobotanical diversity, even taking into account their limitations.
2.9. Needs for Further Research
This study draws our attention to the relevance of the family taxonomic level in
ethnobotany. A few points in which further research is needed have arisen from our
analyses.
The taxonomy of specific and infraspecific taxa in ethnobotanical works is usually
given, as is logical, according to local floras but, as from the consolidation of the APG family
updates, almost all papers use its system for families, which is not coincidental to those
used in floras before APG rearrangements. This creates a difficulty in the comparison of
data related to families in ethnobotanical research, either in one area or in different ones: the
number of families and, more importantly, their rates of presence in each ethnoflora vary
when applying the last classical [70] or the APG systems. An international effort should be
carried out to implement the APG family system in the ethnobotanical databases in order to
facilitate suitable meta-analytic work. Although new prospects will always be positive for
a bigger and better knowledge of plant medicinal uses, at present a considerable amount
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of ethnobotanical information is already accumulated in many parts of the world, so that
this is the appropriate moment to undertake comparative analyses between close and not
so close ethnofloras, following the initiative, here seconded, pioneered by of Moerman [20]
and followed by Weckerle et al. [22] or Dal Cero et al. [23], for which adopting the APG
familiar treatment is important.
Given their relevance in most ethnofloristic surveys, the role of commercially-acquired
plants in the ethnoflora, and the comparison of their uses with those of autochthonous or
allochthonous plants currently present in the flora —and, then, the comparison between
these two categories—is a subject that should be addressed in detail in the different major
geographical areas of the world. At the family level, as treated in this work, 15 families not
present in the local flora (apart from some others present hosting non-native taxa) have
been recorded in a relatively small territory. This is a consequence of cultural exchanges
through time, recently accelerated by the globalisation process.
Finally, a relevant aspect is a relationship between ethnobotany and phytochemistry
(the latter leading to pharmacology and linked to phylogeny). Although there is not
an obvious and unidirectional relationship, and little is known about phytochemical
composition as compared with evolutionary aspects [71], ethnobotanical knowledge has
systematic and evolutionary significance [16,17,71], and thus can help in progressing
in the necessary multidisciplinary approach to ethnopharmacology and ethnomedicine.
Projecting data such as those treated here in a phylogenetic framework has allowed us to
detect hot nodes, richer in families useful in pharmaceutical ethnobotany. Further deeper
combination of ethnobotanical and phylogenetic information within one family or a group
of a few related families could lead to detecting and predicting taxa useful for particular
troubles. Several ethnobotanical works include the phytochemical and/or pharmacological
validation of the folk uses reported or discuss ethnobotanical knowledge in the light of
chemical plant composition [13,72–75], and this will probably be more common in the near
future. Family level is particularly adequate to be addressed for establishing relationships
between chemical composition, phylogenetic aspects and ethnobotanical knowledge, the
three fields confronted either two by two or altogether.
3. Material and Methods
3.1. Data Sources and Field Work Methods
In this study, we used data on plants and their folk medicinal uses obtained from 44
ethnobotanical research prospects (Supplementary Material S1) carried out in the Catalan
linguistic domain (Figure 3). We utilized the use report (hereinafter, UR), i.e., the report of
the use of one taxon by an informant, as the unit of measurement [76]. Veterinary uses are
excluded, and human medicinal uses are classified in 15 troubles or systems categories,
according to Cook [77] with minor modifications. We grouped some categories by affinity
in order to achieve more robustness in the analyses, as some of them had very few reports.
The names of the troubles or system categories have remained as in Cook’s classification
(Table 5), and we just added a new category: tonic and restorative.
The fieldwork method used in these researches was the semistructured interview [9,78],
always taking into account the code of ethics of the International Society of Ethnobiol-
ogy [79], complemented by the collection of plant specimens to be identified and deposited
in public herbaria. All interviews were digitalised, transcribed and introduced into our
database that contains all ethnobotanical data (on medicinal, food and other uses) collected.
3.2. Data Analysis
The simple quantitative analyses of descriptive statistics for categories (species, fami-
lies, and medicinal uses) and the construction of families and disorders matrix (Supplemen-
tary Material S2) were carried out with Excel software (Microsoft Office, 2010). Results were
summarized as heatmaps using the R Phytools package ([80]; R version 3.6.0, [81]) and
the family-level phylogeny of land plants from Zanne et al. [82], pruned to our taxonomic
dataset. We tested whether each node in the phylogeny was significantly more represented
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by a family in a given category of trouble/system than would be expected by chance alone
(i.e., hot nodes; [83]), using the nodesig test originally implemented in the PHYLOCOM
software [84] and adapted for R by Abellán et al. [85].
Figure 3. Map of the territories studied within Europe and the Catalan linguistic area. Dots indicate the areas with
prospections analysed in the present paper.
With the aim of assessing the general state of pharmaceutical ethnobotanical knowl-
edge in the studied area, we calculated the ethnobotanicity index (EI; [31]), which is the
quotient between the number of plants used and the total number of plants that constitute
the flora of the territory, expressed as a percentage. For this purpose, only the plants present
in the Catalan linguistic area’s flora [25] were considered, and 5,500 taxa at specific and
infraspecific level (Sáez, 2019, pers. comm.) were adopted. Furthermore, we adapted this
index to calculate it for families as well.
3.3. Bayesian Method to Evaluate over- and Underused Taxonomic Groups
To evaluate over- and underused flora for the Catalan linguistic domain, 794 medicinal
plant taxa at specific and infraspecific levels with uses reported and included of the flora of
the studied area [25], belonging to 103 families, were recovered from the ethnobotanical
database. The total flora for the same families of the studied area is 4,647 taxa [25]. These
families were assigned to eight taxonomic groups: ANA-grade, early-diverging eudicots,
eudicots-superasterids, eudicots-superrosids, gymnosperms, magnoliids, monocots and
pteridophytes, following Chase et al. [48].
In this scenario our null hypothesis (H0) is the following: For a taxomic group (j),
the proportion of medicinal taxa (θj) is equal to the overall proportion (θ), where θj is a
random variable uniformily distributed between 0 and 1 (prior probability). The posterior
probability can be estimated, its distribution will be conditioned by the observed data
(see [22] for more details). Probability distribution differences from the common proportion
are assessed by all families.
Calculations of the intervals of the most probable values of θ and θj were carried out
by the function which returns the inverse of density of beta probability (INV.BETA.N)
implemented in Excel software (Microsoft Excel 2011).
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3.4. Diversity Indices
In order to quantify the diversity of taxa within the families referred by the infor-
mants, we calculated two diversity indices (Supplementary Material S2). The first one,
the Shannon diversity index [86] from the theory of communication and largely used in
ecology, has also been calculated in some previous ethnobotanical studies [87,88]. This
index, calculated according to the formula Hfam = −Σptaxlog2 ptax, where ptax, represents
the citation frequency of each taxon and assesses the ethnobotanical taxa diversity within
each family, i.e., the family richness from the ethnobotanical point of view. The second
index, k = log S/log N where S is the number of species and N the number of individuals,
proposed by Margalef [89] was adapted and used for the first time in an ethnobotani-
cal study to calculate the diversity within the botanical families following the formula:
k = log T/log UR, where T represents the number of taxa. Pearson’s coefficient correlation
(r) was calculated between these two datasets.
4. Conclusions
The medicinal ethnoflora of the Catalan-speaking territories includes 894 taxa belong-
ing to 120 botanical families of vascular plants. The ethnobotanicity index (EI) is 14.44%
and the familial EI is 68.21% for the studied area. This parameter allows us to compare the
present data with other ethnofloras.
The most common families in the Mediterranean area, such as Lamiaceae (14.40%),
Asteraceae (11.90%) or Rosaceae (5.57%) are among the most cited families which represent
57.34% of total use reports. Fagaceae, Rutaceae and Cannabaceae are the three most
overused families and Cyperaceae, Plumbaginaceae and Poaceae the most underused.
The digestive and nutritional system disorders (11,754 UR, 24.68%), the respiratory
system disorders (6418 UR, 13.47%), skin or subcutaneous tissue disorders (5588 UR,
11.73%) and circulatory system and blood disorders (5299 UR, 11.13%) representing 61.01%
of all use reports are the most cited troubles.
To investigate the degree of phylogenetic clustering of families for each trouble or
system and detect hot nodes for further studies we mapped the reported medicinal uses
grouped in the 15 troubles or systems addressed on the phylogeny of the families.
In the phylogenetic reconstruction, a robust hot node appears in three medicinal
groups: immune system disorders and neoplasia; pain and inflammation; and pregnancy,
birth and puerperal disorders constituted by the Iridaceae, Amaryllidaceae, Asparagaceae,
and Asphodelaceae. The last three families also constitute a hot node clade for tonic and
restorative. Tonic and restorative activities also have another robust hot node, constituted
by Betulaceae, Juglandaceae and Fagaceae. For the endocrine system and metabolic dis-
orders, the clade of Apiaceae and Araliacaeae was detected as relevant. Two robust hot
nodes appear for poisoning, on the one hand Cucurbitaceae and Coriariaceae, and on the
other hand Malvaceae, Cistaceae and Thymelaeaceae. These results centred on the famil-
ial level are appropriate when establishing relationships between chemical composition,
phylogenetic aspects and ethnobotanical knowledge.
Supplementary Materials: The following are available online at https://www.mdpi.com/2223-7
747/10/1/163/s1, S1. References used to elaborate the data matrix analysed; S2. Families and
disorders matrix, and diversity indices.
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